CASP8 and neoplasm: Multiple local administrations of CIMVs-TRAIL into the tumor were associated with the induction of tumor cell death in the CIMV-TRAIL injection group paralleled by remarkable CASP8 activation, which is generally consistent with previous studies on TRAIL antitumor activity.